KSCM
IMGN

Kamunting Street Capital Management’s Immunogen Inc IMGN Stock Holding History

Kamunting Street Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-32,421
Closed -$214K – 91
2021
Q2 		$214K Buy
+32,421
New +$226K 0.09% 76

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kamunting Street Capital Management's IMGN Position: Q3 2021 in Review

Kamunting Street Capital Management sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 32,421 shares — an estimated $214K sold.

Kamunting Street Capital Management first reported a position in IMGN in Q2 2021 and held it in 1 quarter. The position peaked at $214K in Q2 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • Kamunting Street Capital Management reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • Kamunting Street Capital Management sold 32,421 Immunogen Inc shares in Q3 2021, an estimated $214K.
  • Kamunting Street Capital Management first reported a position in Immunogen Inc in Q2 2021 and held it in 1 quarter.
  • Kamunting Street Capital Management's Immunogen Inc position peaked at $214K in Q2 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Kamunting Street Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.